Holy moly… that’s a nose dive
Zeev Bovan
Posts (665)
Pslantir will become a1000$ plus stock but it will take along nerve wrecking time, like an over inflated balloon it will loose air and gain air till the company generate enough profits to justify the insane pe.
Wait for the pipe lines and facilities that would be required, $BKR will triple or at least double.
Going back where it belongs, around 24$, don’t invest in ballon’s, it’s ok to play poker from time to time but if you are playing it for few years and you still don’t know who is the shark and who is the fish you are the fish.
$TARA will pull a Sandisk move eventually
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET
$TARA
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET
$TARA
$NOK beat estimates, my guess is institutions are flashing out weak hands.